Medical Journal of the Islamic Republic Of Iran
مجله پزشکی جمهوری اسلامی ایران
Med J Islam Repub Iran
Medical Sciences
http://mjiri.iums.ac.ir
2
journal2
1016-1430
2251-6840
8
10.18869/mjiri
14
8888
13
en
jalali
1379
11
1
gregorian
2001
2
1
14
4
online
1
fulltext
en
STUDY ON THE EF FICACY OF RECOMBINANT HEPATITIS B VACCINE IN IRANIAN INFANTS
Pediatric
Pediatric
Original Research
Original Research
In order to determine the efficacy of recombinant hepatitis B vaccine in Iranian
infants, we analyzed the efficacy of a recombinant hepatitis B vaccine in 115
infants aged 12-24 months born to HBsAg negative mothers who received three
doses of HBV Antibody to hepatitis B surface antigen (anti-HBs) was checked
after the third dose of the vaccine, 94.8% of the infants had developed protective
antibody levels. The vaccine was well-tolerated and no serious adverse effects
were reported.
This study is in agreement with a WHO report which recommends that the
easiest and most cost-effective strategy for the control and eventual eradication of
HBV would be to immunize all newborns with hepatitis B vaccine only [World
Health Organization report, 1984].
hepatitis B vaccine, infant, efficacy, immunization.
347
349
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-298-289&slc_lang=en&sid=1
A
ZAMANI
20031947532846004276
20031947532846004276
Yes
From the Departments of Pediatrics School of Medicine, Tehran University of Medical Sciences, Tehran, I.R. Iran.
H
SHAJARI
20031947532846004277
20031947532846004277
No
From the Departments of Neonatology, School of Medicine, Tehran University of Medical Sciences, Tehran, I.R. Iran.
I
SEDIGHY
20031947532846004278
20031947532846004278
No
From the Departments of Pediatrics School of Medicine, Tehran University of Medical Sciences, Tehran, I.R. Iran.